COVID-19 Drug Development

COVID-19 drug development is a research process to discover a preventative and therapeutic prescription of drugs that would control the severity of coronavirus disease. From 2020 to 2021, various drug companies, biotechnology firms, university research groups, and health organizations were started developing over 600 potential therapies for corona virus disease with various stages of preclinical or clinical research, with 391 therapeutic candidates in clinical trials, as of January 2021.

PDDS 2022 Speakers
Speaker at Pharmaceutics and Drug Delivery Systems 2022 - Alena Korbut

Alena Korbut

IHS/Cherokee Nation, United States
Speaker at Pharmaceutics and Drug Delivery Systems 2022 - Victoria Demina

Victoria Demina

NEUWAY Pharma GmbH, Germany
Speaker at Pharmaceutics and Drug Delivery Systems 2022 - Samir Haddouchi

Samir Haddouchi

Sotax Pharma Services, France
Speaker at Pharmaceutics and Drug Delivery Systems 2022 - Miroslav Radenkovic

Miroslav Radenkovic

University of Belgrade, Serbia
Speaker at Pharmaceutics and Drug Delivery Systems 2022 - Mirjana B. Colovic

Mirjana B. Colovic

University of Belgrade, Serbia
Speaker at Pharmaceutics and Drug Delivery Systems 2022 - Madhav Bhatia

Madhav Bhatia

University of Otago, New Zealand

Submit your abstract Today

Watsapp